Search - tctmd.com

Displaying 21 - 40 of 60

Sort: Relevancy | Date

Presentation TCT 2015

TCT 103: National Variation in Post-TAVR Antithrombotic Therapy Utilization and Associated Outcomes Insights From the STS/ACC TVT Registry

Presenter: Michael J. Reardon, Torsten P. Vahl, Matthew Sherwood

October 13, 2015

Presentation TCT 2015

TCT 102: SAPIEN 3 Implantation in Failed Surgical Aortic Bioprostheses Matched Comparison and Insights From the Valve-in-Valve International Data (VIVID) Registry

Presenter: Michael J. Reardon, Torsten P. Vahl, Moritz Seiffert

October 13, 2015

Presentation TCT 2015

TCT 101: Experience With Cerebral Protection During Transcatheter Aortic Valve Replacement The ALSTER Registry

Presenter: Michael J. Reardon, Torsten P. Vahl, Tobias Schmidt

October 13, 2015

Presentation TCT 2015

TCT 100: Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease One-Year Outcomes From the CoreValve US Expanded Use Study

Presenter: Michael J. Reardon, Torsten P. Vahl, Daniel O'Hair

October 13, 2015

Presentation TCT 2015

Aortic Valve Patho-Biology: Anatomical Implications for TAVR Performance

Presenter: Raj Makkar, Michael J. Reardon, James M. McCabe

October 13, 2015

Presentation TCT 2015

Intra-Procedural Echo Guidance in TAVR Procedures

Presenter: Raj Makkar, Michael J. Reardon, Rebecca T. Hahn

October 13, 2015

Presentation TCT 2015

Practical Echo Reading and Analysis of Aortic Annulus and Associated Structures

Presenter: Raj Makkar, Michael J. Reardon, Rebecca T. Hahn

October 13, 2015

Presentation TCT 2015

The Human Aortic Valve: Technical Landmarks and Considerations for TAVR Implantation

Presenter: Raj Makkar, Michael J. Reardon, James M. McCabe

October 13, 2015

Presentation TCT 2015

Vascular Access and Closure Techniques: A Step Wise Approach

Presenter: Raj Makkar, Michael J. Reardon, Torsten P. Vahl

October 13, 2015

News Conference News TCT 2015

Updates to CoreValve Extreme Risk Study Encouraging

October 13, 2015

Presentation TCT 2015

Poor Femoral Access and TAVR (Alternative Access): Thoughtful Commentary on the Case

Presenter: Howard C. Herrmann, Patrick T. O'Gara, Michael J. Reardon

October 12, 2015

Presentation TCT 2015

InSeal: Intravascular Closure Device

Presenter: Alain G. Cribier, Eberhard Grube, Robert J. Applegate, Stephen J.D. Brecker, Todd J. Brinton, Philippe Généreux, A. Pieter Kappetein, Michael J. Reardon, Josep Rodés-Cabau

October 12, 2015

Presentation TCT 2015

Updates From the US CoreValve Studies 1: Follow-up From the Extreme and High-Risk Subgroups

Presenter: Samir R. Kapadia, Jeffrey J. Popma, Michael J. Reardon

October 11, 2015

News Daily News

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

July 07, 2015

News Daily News

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

July 07, 2015

Presentation

2-Year Outcomes in Patients Undergoing Surgery or Self-Expanding TAVR

Presenter: Michael J. Reardon

July 06, 2015

Presentation TVT 2015

A Surgeons View: Will I Be in the Room in the Future?

Presenter: Susheel K. Kodali, David A. Wood, Michael J. Reardon

June 06, 2015

Presentation TVT 2015

CoreValve US 2-Year Follow-up

Presenter: Michael J. Reardon

June 05, 2015

Presentation TVT 2015

The Importance of Correct Valve Sizing in Surgical and Transcatheter AVR

Presenter: Jonathon A. Leipsic, Jeffrey J. Popma, Michael J. Reardon

June 05, 2015

Presentation TVT 2015

Thoughtful Commentary: Poor Femoral (Alternative) Access and TAVR

Presenter: Neil E. Moat, Allan Schwartz, Michael J. Reardon

June 05, 2015

Advertisement

TCT 103: National Variation in Post-TAVR Antithrombotic Therapy Utilization and Associated Outcomes Insights From the STS/ACC TVT Registry

TCT 102: SAPIEN 3 Implantation in Failed Surgical Aortic Bioprostheses Matched Comparison and Insights From the Valve-in-Valve International Data (VIVID) Registry

TCT 101: Experience With Cerebral Protection During Transcatheter Aortic Valve Replacement The ALSTER Registry

TCT 100: Transcatheter Aortic Valve Replacement in Patients With End-Stage Renal Disease One-Year Outcomes From the CoreValve US Expanded Use Study

Aortic Valve Patho-Biology: Anatomical Implications for TAVR Performance

Intra-Procedural Echo Guidance in TAVR Procedures

Practical Echo Reading and Analysis of Aortic Annulus and Associated Structures

The Human Aortic Valve: Technical Landmarks and Considerations for TAVR Implantation

Vascular Access and Closure Techniques: A Step Wise Approach

Updates to CoreValve Extreme Risk Study Encouraging

Poor Femoral Access and TAVR (Alternative Access): Thoughtful Commentary on the Case

InSeal: Intravascular Closure Device

Updates From the US CoreValve Studies 1: Follow-up From the Extreme and High-Risk Subgroups

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

El Beneficio sobre la Supervivencia de CoreValve en Pacientes de Alto Riesgo se Mantiene a los 2 Años

2-Year Outcomes in Patients Undergoing Surgery or Self-Expanding TAVR

A Surgeons View: Will I Be in the Room in the Future?

CoreValve US 2-Year Follow-up

The Importance of Correct Valve Sizing in Surgical and Transcatheter AVR

Thoughtful Commentary: Poor Femoral (Alternative) Access and TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content